Please find enclosed, Company''s response.

Date: 1st October, 2026 BSE Limited P. J. Towers, Dalal Street, Fort, Mumbai – 400 001 Ref.: BSE Scrip Code No. “533138” Dear Sir / Madam, Sub.: Reply on Significant Increase in the Volume of Security across Exchanges, in the recent past Ref.: Your E-mail Ref. No. L/SURV/ONL/PV/SG/ 2026-2027 / 406 dated 1st October, 2026 With reference to your captioned E-mail bearing Ref. No.: L/SURV/ONL/PV/SG/ 2026-2027 / 406 dated 1st October, 2026, we wish to inform you that as a Listed Company, we are conscious of our responsibility to disseminate to the Stock Exchanges, information that could have an impact on the price of the Company’s shares. Consistent with this approach, we have been promptly disseminating to the Stock Exchanges, events or information which are required to be disclosed pursuant to the Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“the Listing Regulations”). We hereby confirm that we are in compliance with respect to disclosures that are required to be made under the Listing Regulations and also confirm that there are no developments that have taken place requiring mandatory disclosure under Listing Regulations or the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (“PIT Regulations”). Please be assured that as a responsible corporate citizen we would fully comply with our obligations under the Listing Regulations and / or PIT Regulations and would make appropriate disclosures as mandated under the applicable regulations as and when required. Kindly take the above information on your records. Thanking you, Yours sincerely, For Astec LifeSciences Limited Tejashree Pradhan Company Secretary & Compliance Officer (FCS 7167)